We recently discovered that human nasal ciliated cells express the T2R bitter taste receptors. When activated by secreted bacterial products, T2Rs in cilia stimulates an innate immune signaling cascade involving calcium-driven nitric oxide production that increases ciliary beating as well as directly kills bacteria. Genetic polymorphisms in the TAS2R38 gene, one of the T2Rs in cilia, may underlie susceptibility to infection in patients with chronic rhinosinusitis. We hypothesize that activation of T2R bitter receptor responses in airway ciliated cells will activate innate immune to help eradicate infections without the use of conventional antibiotics. Understanding how to develop topical therapeutics targeting these pathways requires further knowledge of the identity of other cilia-localized chemosensory receptors in cilia as well as their signaling pathways and downstream effects. There remains a critical need for knowledge of the cell biology and physiology of extraoral taste receptors in general. We hypothesize that sinonasal and bronchial motile cilia express multiple chemosensory receptors, as we have identified multiple T2Rs (4,14,16, and 38) and T1Rs 2 and 3 (components of the sweet taste receptor) localized to sinonasal cilia. Interestingly, T2Rs and T1Rs activate different pathways, in contrast to the tongue where their intracellular signaling is similar. Cilia T2Rs activate Ca2+-dependent NO production, possibly also involving the kinase AKT. Activation of cilia T1R2/3 activates a distinct signaling pathway that regulates airway epithelial glucose transporters. Understanding cilia chemosensation and the unique signaling pathways involved will shed light on how to leverage these receptors for therapeutic benefit as well as elucidate mechanisms of non-canonical taste receptor signaling that may be highly relevant to the tongue and/or the many extraoral tissues where they are expressed.
In Aim 1, we will further elucidate the signaling of cilia T2Rs using a combination of live cell imaging, biochemical, and molecular approaches in differentiated primary human cells and cell lines cultured at air-liquid interface.
In Aim 2, we will use similar techniques to elucidate the signaling mechanism by which T1R receptors regulate glucose transport in the airway as well as its regulation by T1R receptors in primary human and mouse cells.
In Aim 3, we will examine the localization and interactions of T1Rs and T2Rs using a combination of live-cell imaging and biochemistry, as well as identify the cilia chemosensory repertoire by biochemical cilia purification and proteomics. Together, the independent yet inter-related aims will examine important chemosensory functions of airway cilia, revealing new ways to leverage chemosensory receptors as therapeutic targets for airway diseases. Equally importantly, we will reveal new insights into the cell biology of extraoral taste receptor function that will likely translate to T1Rs and T2Rs in other tissues. While much of T2R and T1R cell biology has been inferred from heterologous systems, our unique model system will allow us to study the function and interactions of endogenous T1R and T2R function in differentiated primary human cells.

Public Health Relevance

When you inhale harmful bacteria, they can stimulate taste receptors expressed in ciliated cells of the nose to activate an antibacterial defense response. Airway ciliated cells express both bitter and sweet taste receptors, which appear to also play roles in production of antibacterial compounds, transport of glucose, and cellular metabolism. The goal of this research is to understand which taste receptors are expressed in airway cell cilia of both the nose/sinuses and the lung as well as to determine what their functions are, because we believe that pharmacologically targeting them may help to stimulate beneficial innate immune responses in patients with respiratory infections.

Agency
National Institute of Health (NIH)
Institute
National Institute on Deafness and Other Communication Disorders (NIDCD)
Type
Research Project (R01)
Project #
5R01DC016309-04
Application #
10111502
Study Section
Somatosensory and Chemosensory Systems Study Section (SCS)
Program Officer
Sullivan, Susan L
Project Start
2018-03-01
Project End
2023-02-28
Budget Start
2021-03-01
Budget End
2022-02-28
Support Year
4
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Otolaryngology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104